Cabot Corporation (CBT) Financials
CBT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 3.7 billion | 2.2 billion |
| 2023-09-30 | 3.6 billion | 2.2 billion |
| 2023-06-30 | 3.4 billion | 2.1 billion |
| 2023-03-31 | 3.5 billion | 2.3 billion |
CBT Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 51.0 million | 6.0 million |
| 2023-09-30 | 60.0 million | 5.0 million |
| 2023-06-30 | 163.0 million | 3.0 million |
| 2023-03-31 | 111.0 million | 6.0 million |
CBT Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 61.0 million |
| 2023-09-30 | 246.0 million |
| 2023-06-30 | 90.0 million |
| 2023-03-31 | 82.0 million |
CBT Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 244.0 million | - | - |
| 2023-09-30 | 238.0 million | - | 84.0 million |
| 2023-06-30 | 220.0 million | 1.1 billion | - |
| 2023-03-31 | 205.0 million | 1.1 billion | - |
CBT Shares Outstanding
CBT Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 54.0 million | 15.0 million | 67.0 million | - |
| 2023-09-30 | 78.0 million | 14.0 million | 69.0 million | - |
| 2023-06-30 | 80.0 million | 15.0 million | 58.0 million | - |
| 2023-03-31 | 51.0 million | 15.0 million | 66.0 million | - |
CBT Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 958.0 million | 740.0 million |
| 2023-09-30 | 965.0 million | 740.0 million |
| 2023-06-30 | 968.0 million | 745.0 million |
| 2023-03-31 | 1.0 billion | 823.0 million |
CBT
List: Contenders
Price: $93.40
Dividend Yield: 0.02%
Forward Dividend Yield: 1.71%
Payout Ratio: 20.70%
Dividend Per Share: 1.60 USD
Earnings Per Share: 7.68 USD
P/E Ratio: 9.20
Exchange: NYQ
Sector: Basic Materials
Industry: Specialty Chemicals
Volume: 414800
Ebitda: 144.0 millionMarket Capitalization: 5.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 41
DGR3: 1.88%
DGR5: 3.29%
DGR10: 7.51%
DGR20: 6.00%